TUNICRIS-julkaisut - Trepo

Viitteet 1-1 / 1

The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age

Curran, Desmond; Matthews, Sean; Cabrera, Eliazar Sabater; Pérez, Silvia Narejos; Breva, Lina Pérez; Rämet, Mika; Helman, Laura; Park, Dae Won; Schwarz, Tino F; Melendez, Isabel Maria Galan; Schaefer, Axel; Roy, Nathalie; Stephan, Brigitte; Molnar, Daniel; Kostanyan, Lusine; Powers, John H; Hulstrøm, Veronica (02 / 2024)
article

BACKGROUND: Respiratory syncytial virus (RSV) is a contagious pathogen causing acute respiratory infections (ARIs). Symptoms range from mild upper respiratory tract infections to potentially life-threatening lower respiratory ...